Oral nitrates: More than symptomtatic therapy in coronary artery disease?

Cardiovascular Drugs and Therapy

Volumn 11, Issue SUPPL. 1, 1997, Pages 213-218

  Thadani, Udho ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Angina pectoris; Coronary heart disease; Myocardial infarction; Nitrates

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIUM DERIVED RELAXING FACTOR; HYDRALAZINE; ISOSORBIDE DINITRATE; NITRATE; NITRIC OXIDE; VASODILATOR AGENT;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERANCE; EXERCISE TOLERANCE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MORBIDITY; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK; THORAX PAIN; THROMBOCYTE AGGREGATION; UNSTABLE ANGINA PECTORIS; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG COMBINATION; DRUG EFFECT; HEMODYNAMICS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADMINISTRATION, ORAL; ANGINA PECTORIS; CORONARY DISEASE; DRUG THERAPY, COMBINATION; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MYOCARDIAL INFARCTION; NITRATES; RANDOMIZED CONTROLLED TRIALS; VASODILATOR AGENTS;

EID: 0031132630     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007750706831     Document Type: Article

References (76)

1. McGregor M. Pathogenesis of angina pectoris and role of nitrates in relief of myocardial ischemia. Am J Med 1983;74(Suppl 4):21-27.
2. Ferrer MI, Bradley SE, Wheeler HO, et al. Some effects of nitroglycerin upon the splanchnic, pulmonary and systemic circulation. Circulation 1986;33:357-373.
3. Bassange E, Strein K. Dose dependent effects of isosorbide-5-mononitrate on the venous, arterial and coronary arterial system of conscious dogs. Naunyn Schmiedergs Arch Pharmacol 1986;334:100-104.
4. Winbury WH, Howe BB, Weiss HR. Effect of nitroglycerin and dipyridamole on epicardial and endocardial oxygen tension: Further evidence for redistribution of myocardial flow. J Pharmacol Exp Ther 1971;176:184-199.
5. Jugdutt Bl, Becker LC, Hutchins GM, et al. Effect of intravenous nitroglycerin on collateral blood flow and infarct size in the conscious dog. Circulation 1981;63:17-28.
6. Fallen EL, Nahmias C, Scheffel A, et al. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation 1995;91:1381-1388.
7. Thadani U, Whitsett T, Hamilton SF. Nitrate therapy for myocardial ischemic syndromes: Current prospectives including tolerance. Curr Prob Cardiol 1988;13:725-784.
8. Abrams JA. A reappraisal of nitrate therapy. JAMA 1988;256:396-401.
9. Thadani U, Lipicky RJ. Ointments and transdermal nitroglycerin patches for stable angina pectoris. Cardiovasc Drugs Ther 1994;8:625-633.
10. Thadani U, Lipicky RJ. Short and long-acting nitrates for stable angina pectoris. Cardiovasc Drugs Ther 1994;8:611-623.
11. Palmer RMJ, Ferrige AC, Moncada S. Nitric oxide release accounts for the biological activity of endothelial derived relaxing factor. Nature 1987;327:524-526.
12. Harrison DG, Kurz MA, Quillen JE, et al. Normal and pathophysiologic consideration of endothelial regulation of vascular tone and their relevance to nitrate therapy. Am J Cardiol 1992;70:11B-17B.
13. Yeung AC, Vekshtein VI, Krantz DS, et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991;3235:1551-1556.
14. Gage JE, Hess DM, Murakami T, et al. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classical angina pectoris: Reversibility by nitroglycerin. Circulation 1986;73:865-876.
15. Chung SJ, Fung HL. Relationship between nitroglycerin induced vascular relaxation and nitric oxide production: Problems with inhibition and tolerance development. Biochem Pharmacol 1983;45:157-163.
16. Ignarro LJ, Lippton H, Edward JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitroprusside and nitric oxide: Evidence of the involvement of 5-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739-749.
17. Kukovetz WR, Holzmann S. Mechanism of nitrate induced vasodilation tolerance. Z Kardiol 1983;72(suppl 3):14-19.
18. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 1986;78:1-5.
19. Goldstein RE, Bennett ED, Leech GL. Effects of glyceryl trinitrate on echocardiographic ventricular dimensions during exercise in the upright position. Br Heart J 1979;42:245-254.
20. Bassange E. Nitrates in different vascular beds: Nitrate tolerance, and interaction with endothelial function. Am J Cardiol 1992;70:23B-29B.
21. Brown BG, Bolson E, Petersen RB, et al. The mechanisms of nitroglycerine action: Stenosis dilation as a major component of drug response. Circulation 1981;64:1089-1097.
22. Winbury MM, Howe BB, Hefner MA. Effect of nitrates and other coronary dilators on large and smaller coronary vessels: A hypothesis for the mechanism of action of nitrates. J Pharmacol Exp Ther 1969;168:70-95.
23. Winbury WM, Howe BB, Weiss HR. Effect of nitroglycerin and dipyridamole on epicardial and endocardial oxygen tension: Further evidence for redistribution of myocardial flow. J Pharmacol Exp Ther 1971;176:184-199.
24. Thadani U, Opie LH. Nitrates. In: Opie LH, ed. Drugs for the Heart, 4th ed. Philadelphia: W.B. Saunders, 1995;31-48.
25. Jugdutt Bl, Khan MI, Tang SB, Deware J. Prompt and persistent recovery of ventricular function and attenuation of ventricular geometry after late reperfusion and prolonged nitrate therapy in canine anterior myocardial infarction. J Am Coll Cardiol 1991;17 (Suppl A):373A.
26. Jugdutt Bl, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complications: Effects of timing, dosage and infarct size. Circulation 1988;78:906-919.
27. Humen DP, McCormick L, Jugdutt Bl. Chronic reduction in left ventricular volumes at rest and exercise in patients treated with nitroglycerin following anterior MI (abstr). J Am Coll Cardiol 1989;13:25A.
28. McDonald KM, Francis GS, Mathews J, Hunter D, Cohn JH. Long-term oral nitrate therapy prevents chronic ventricular remodelling in the dog. J Am Coll Cardiol 1993;21:514-522.
29. Sharpe N, Smith H, Murphy J, et al. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin converting enzyme inhibition. Lancet 1991;337:872-876.
30. Pfeffer MA, Braunwald E, Moyé LA. Effect of captopril on mortality and morbidity with left ventricular dysfunction after myocardial infarction. N Eng J Med 1992;327:669-677.
31. Jugdutt Bl. Prevention of ventricular remodelling post myocardial infarction: Timing and duration of therapy. Can J Cardiol 1993;9:103-114.
32. Lam JYT, Chesbro JH, Fuster V. Platelets, vasoconstriction and nitroglycerin during arterial wall injury. A new anti-thrombotic role of an old drug. Circulation 1988;78:712-716.
33. Folts JD, Stamler J, Loscalzo J. Intravenous nitroglycerin infusion inhibits cyclic blood flow response caused by periodic platelet thrombus formation in stenosed coronary arteries. Circulation 1991;83:2122-2127.
34. Stamler JS, Loscalzo J. The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance in cardiovascular disorders. J Am Coll Cardiol 1991;18:1529-1536.
35. Diodati, Théroux P, Latour J-G, et al. Effects of nitroglycerin at therapeutic doses on platelet aggregation: Unstable angina and acute myocardial infarction. Am J Cardiol 1990;66:683-688.
36. Thadani U, Fung HL, Darke AC, et al. Oral isosorbide dinitrate in angina pectoris: Comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol 1982;49:411-419.
37. Thadani U, Manyari D, Parker JO, et al. Tolerance to the circulatory effects of oral isosorbide dinitrate: Rate of development and cross tolerance to glyceryl trinitrate. Circulation 1980;61:526-535.
38. Thadani U. Nitrate tolerance: How to prevent it or minimize its effect. Postgrad Med 1992;91:307-318.
39. Thadani U, Fung HL, Darke AC, et al. Oral isosorbide dinitrate in angina pectoris: Comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol 1982;49:411-419.
40. Steering Committee; Transdermal Nitroglycerin Cooperative Study. Acute and chronic antianginal efficacy of continuous 24-hour application of transdermal nitroglycerin. Am J Cardiol 1991;63:1263-1273.
41. Demots H, Glasser SP, and the Transderm Nitro Study Group. Intermittent nitroglycerin therapy in treatment of stable angina. J Am Coll Cardiol 1989;13:786-793.
42. Thadani U, Maranda C, Amsterdam E, et al. Lack of pharmacologic tolerance and rebound angina pectoris during twice daily therapy with isosorbide-5-mononitrate. Ann Intern Med 1994;120:353-359.
43. Parker JO and the Isosorbide-5-mononitrate Study Group. Eccentric dosing with isosorbide-5-mononitrate in angina pectoris. Am J Cardiol 1993;72:871-876.
44. Chrysant SG, Glasser SP, Bittar N, et al. Efficacy and safety of extended release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol 1993;72:1249-1256.
45. Dauwe F, Affaki G, Waters DD, et al. Intravenous nitroglycerin in refractory unstable angina (abstr). Am J Cardiol 1979;43:416.
46. Page A, Hurtle JF, Roudaut R, et al. Intravenous trinitrin in the treatment of pre-infarctional angina. Nouve Presse Med 1979;8:268-270.
47. Brodsky SJ, Halperin JL, Klein MD, et al. Intravenous nitroglycerin infusion in unstable angina (abstr). Clin Res 1980;28:608.
48. Mikolich RJ, Nicoloff NB, Robinson PH, et al. Relief of refractory angina with continuous intravenous infusion of nitroglycerin. Chest 1980;77:375-379.
49. DePace ML, Hering IM, Kotler MN, et al. Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action. Arch Intern Med 1982;142:1806-1809.
50. Roubin GS, Harris PJ, Eckhardt L, et al. Intravenous nitroglycerin in refractory unstable angina pectoris. Aust N Z J Med 1982;12:598-602.
51. Squire A, Cantor R, Packer M. Limitations of continuous intravenous nitroglycerin prophylaxis in patients with refractory angina at rest (abstr). Circulation 1982;66(Suppl II):II120.
52. Curfman GD, Heinsimer JA, Lozner EC, et al. Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: A prospective, randomized trial. Circulation 1983;67:276-283.
53. Kaplan K, Davison R, Parker M, et al. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. Am J Cardiol 1983;51:694-698.
54. Thadani U, Sharma M, Thompson D, et al. Intravenous nitroglycerin and tolerance in unstable angina (abstr). Circulation 1987;76(Suppl IV):IV128.
55. Disdante A, Maseri A, Severi S, et al. Management of vasospastic angina at rest with continuous infusion of isosorbide dinitrate. Am J Cardiol 1979;44:533-539.
56. Conti R. Use of nitrates in unstable angina pectoris. Am J Cardiol 1987;60:31H-34H.
57. Thadani U. Nitrate therapy in unstable angina. In: Bleifleld W, Hamm CW, Braunwald E, eds. Unstable Angina. Berlin: Springer-Verlag, 1990:203-213.
58. Horowitz JD. Role of nitrates in unstable angina pectoris. Am J Cardiol 1992;70(Suppl):64B-71B.
59. Thadani, U, Opie LH. Nitrates for unstable angina. Cardiovasc Drugs Ther 1994;8:719-726.
60. Bussmann WD, Schupp D. Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema. Am J Cardiol 1978;41:931-936.
61. Chatterjee K, Parmley W, Swan HJC, Berman G, et al. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunctional subvalvular apparatus. Circulation 1973;48:684-690.
62. Bussmann WD, Passek D, Seidel W, Kaltenbach M. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin. Circulation 1981;63:615-62.
63. Jaffe AS, Geltman EM, Tiefenbrunn AJ, et al. Reduction of infarct size in patients with inferior infarction with intravenous nitroglycerin. Circulation 1981;63:615-622.
64. Flaherty JR, Becker LC, Bulkley BH, et al. A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction. Circulation 1983;68:576-588.
65. Philis A, Flather M, Collins R, Foster C, Sleight P. Effects on ventricular arrhythmias of oral captopril and moninitrate started early in acute myocardial infarction: Results of a randomized placebo controlled trial. Br Heart J 1993;69:161-165.
66. Philis A, Flather M, Collins R, Coats A, et al. Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: A randomized placebo-controlled study. J Am Coll Cardiol 1993;22:73-79.
67. Hildebrandt P, Torp-Pedersen C, Joen C, et al. Reduced infarct size in non-perfused myocardial infarction by combined infusion of isosorbide dinitrate and streptokinase. Am Heart J 1992;124:1139-1144.
68. Yusuf S, Collins R, MacMohan S, Peto R. Effect of intravenous nitrates in acute myocardial infarction: An overview of the randomized trials. Lancet 1988;1:1088-1092.
69. Held P. Effects of nitrates on mortality in acute myocardial infarction and in heart failure. Br J Clin Pharmacol 1992;34:25S-28S.
70. ISIS-4. A randomized factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58,500 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
71. GISSI 3. Effects of lisinopril and transdermal glyceryl trinitrate single and together on 6 week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-1122.
72. The ESPRIM Trial. Short-term treatment of acute myocardial infarction with molsidomine. Lancet 1994;344:91-96.
73. Kinch JW Ryan TJ. Right ventricular infarct. N Eng J Med 1994;330:1211-1217.
74. Schneider W, Bussmann WD, Hartmann A, Kaltenbach M. Nitrate therapy in heart failure. Cardiology 1991;79 (Suppl 2):5-13.
75. Cohn JN, Archibald D, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic heart failure. Results of a Veterans Administration Cooperative Study (V-Heft). N Engl J Med 1986;314:1547-1552.
76. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Eng J Med 1991;325:303-310.